Nonvenereal endemic syphilis
Nonvenereal endemic syphilis (also known as bejel, endemic syphilis, or nonvenereal syphilis) is a chronic bacterial disease caused by the Treponema pallidum subspecies endemicum. This disease is primarily transmitted through close personal contact and is most commonly found in arid regions, such as the Middle East and North Africa.
Etiology
Nonvenereal endemic syphilis is caused by the bacterium Treponema pallidum subspecies endemicum. This bacterium is closely related to the one that causes venereal syphilis, but it is adapted to non-sexual transmission.
Epidemiology
Nonvenereal endemic syphilis is most commonly found in arid regions, such as the Middle East and North Africa. It is primarily transmitted through close personal contact, often among children. The disease is endemic in these regions, meaning it is constantly present at a low level.
Clinical Presentation
The symptoms of nonvenereal endemic syphilis are similar to those of venereal syphilis, but they tend to be less severe. The disease typically begins with a lesion in the mouth or throat, which is followed by a rash on the skin and mucous membranes. If left untreated, the disease can progress to affect the bones and central nervous system.
Diagnosis
Diagnosis of nonvenereal endemic syphilis is typically made based on the clinical presentation and history of exposure. Laboratory tests, such as serologic tests for syphilis, can also be used to confirm the diagnosis.
Treatment
Treatment for nonvenereal endemic syphilis typically involves antibiotics, such as penicillin. With appropriate treatment, the prognosis for this disease is generally good.
Prevention
Prevention of nonvenereal endemic syphilis primarily involves avoiding close personal contact with infected individuals. In endemic regions, public health measures such as improved sanitation and hygiene can also help to reduce the spread of the disease.

This article is a infectious disease stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian